Bright Path Laboratories news
Bright Path Labs is proud to announce its admittance to the Green Chemistry and Commerce Council (GC3)! We are eager to learn from and collaborate with leaders in sustainable and green technologies across different sectors. Our technology and approach are deeply rooted in Green Chemistry’s 12 Principles, so we are thrilled to participate in an organization of firms that uphold and put into practice these fundamentals. Read more about Bright Path’s recent ascension into the group a
Bright Path CEO Tony Quinone joins Yahoo Finance to discuss how the Build Back Better Plan will promote locally produced pharmaceutical drugs.
Bright Path Labs has appointed Mr. Marc Fasteau as an independent director. Tony Quinones, CEO of BPL, stated, “We are extraordinarily honored and pleased that Mr. Fasteau has elected to join our board as an independent director.” Mr. Fasteau is a lawyer, former partner at New York investment bank Dillon Read and founder and former chairman of the American Strategic Insurance, property & casualty insurance group. Mr. Fasteau serves on the board of Oxford Performance Mate
Bright Path Laboratories, Inc. (privately held) 3-year-old startup contract manufacturer – with offices in both Charlotte and Santa Fe, N.M. – recently got a strong show of support from The U.S. Food and Drug Administration for its patented spinning-tube-in-tube (STT) continuous-flow reactor.
The agency accepted the system, the only one of its kind that manufactures active pharmaceutical ingredients (APIs), into the FDA’s